Politiparty
Politiparty

118th Congress Health

H.R. 5385: Medicare PBM Accountability Act

Introduced

  1. Introduced (completed)Sep 12, 2023
  2. Passed House (not reached)
  3. Passed Senate (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in House, Sep 12, 2023

This bill establishes reporting requirements for pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage, particularly relating to the prices of prescription drugs.

Specifically, PBMs must (1) disclose certain information underlying cost performance measurements (e.g., exclusions and terms), and (2) report to prescription drug plan (PDP) sponsors (and to the Centers for Medicare & Medicaid Services upon request) an itemized list of prescription drugs that were dispensed during the previous year and related data about costs, claims, affiliated pharmacies, and other specified information. PDP sponsors may audit PBMs to ensure compliance with this bill's requirements and must annually certify their compliance; PBMs are responsible for any associated civil penalties for violations.

In addition, the Government Accountability Office must study federal and state reporting requirements for health plans and PBMs with respect to prescription drug price transparency and recommend ways to streamline these requirements.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

1

Bipartisan support.

Who scored on this bill

6 points earned
  1. 1Greg Landsman D-OH SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Greg Landsman

History

  1. Sep 12, 2023Introduced in the House by Greg Landsman.
Show the full action history (9 actions)
  1. Dec 17, 2024Referred to the Subcommittee on Health.
  2. Dec 6, 2023Committee Consideration and Mark-up Session Held
  3. Dec 6, 2023Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.
  4. Dec 5, 2023Committee Consideration and Mark-up Session Held
  5. Nov 15, 2023Subcommittee Consideration and Mark-up Session Held
  6. Nov 15, 2023Forwarded by Subcommittee to Full Committee by Voice Vote.
  7. Sep 15, 2023Referred to the Subcommittee on Health.
  8. Sep 12, 2023Introduced in House
  9. Sep 12, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.